Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

SRR8518258

· D

6108a9bd-fb2f-5c79-ba14-95c9cff5778c

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
D
subtype
D

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • PROTEIN_SECRETION+0.240
  • BILE_ACID_METABOLISM+0.090
  • NOTCH_SIGNALING+0.090
  • TGF_BETA_SIGNALING+0.080
  • WNT_BETA_CATENIN_SIGNALING+0.070
  • MITOTIC_SPINDLE+0.060
  • ANDROGEN_RESPONSE+0.050
  • HEME_METABOLISM+0.020
  • PI3K_AKT_MTOR_SIGNALING+0.020
  • HEDGEHOG_SIGNALING-0.020

Top 10 suppressed

  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.480
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.470
  • ANGIOGENESIS-0.430
  • MTORC1_SIGNALING-0.370
  • IL6_JAK_STAT3_SIGNALING-0.350
  • INTERFERON_GAMMA_RESPONSE-0.350
  • APICAL_JUNCTION-0.330
  • UNFOLDED_PROTEIN_RESPONSE-0.320
  • COAGULATION-0.310
  • INTERFERON_ALPHA_RESPONSE-0.310

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

7 twins match this tumor's tissue · 3 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1MDT-AP-0189
medullo-epn-umap@date-based
MedMedulloblastoma0.875
2MNG45
mng-umap@100
0.874
3SRR12475149
colon-landscapes@1
0.870
4TCGA-E7-A6MF-01A-12R-A32O-07
bladder-landscape@3
0.865
5TCGA-GU-A42R-01A-11R-A23N-07
bladder-landscape@3
0.860
6MDT-AP-3246
medullo-epn-umap@date-based
MedMedulloblastoma0.860
7SRR8942980
bladder-landscape@3
0.859
8SRR8518450
breast-umap@18
A0.858
9SJEPD030911_D1.RNA-Seq
medullo-epn-umap@date-based
EPNPosterior Fossa EPN0.857
10SRR650132
bladder-landscape@3
0.856

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 9 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.240Remibrutinib— uncovered
BILE_ACID_METABOLISM0.090Inavolisib— uncovered
NOTCH_SIGNALING0.090Inavolisib— uncovered
TGF_BETA_SIGNALING0.080Inavolisib— uncovered
WNT_BETA_CATENIN_SIGNALING0.070Inavolisib— uncovered
MITOTIC_SPINDLE0.060Inavolisib— uncovered
ANDROGEN_RESPONSE0.050Inavolisib— uncovered
HEME_METABOLISM0.020Temsirolimus— uncovered
PI3K_AKT_MTOR_SIGNALING0.020Inavolisib— uncovered